by Sebastian | Mar 17, 2022 | News
Gilde Healthcare Private Equity IV (GHPE IV) has closed at €517m for investments in proifitable healthcare companies in the lower mid-market in North-west Europe. The new oversubscribed fund will focus its investements on firms with an active buy-and-build strategy...
by Sebastian | Mar 17, 2022 | News
Clayton Dubilier & Rice is returning to the fundraising trail with a new buyout fund nearly a year after wrapping up its predecessor with approximately $16bn, according to four people familiar with the fundraising efforts. The firm has begun talking to investors...
by Sebastian | Mar 17, 2022 | News
BEX Capital, an investment firm focused exclusively on secondaries in private equity fund-of-funds (FoF), secondaries funds and co-investment funds, has closed BEX Fund IV at 765m, in excess of its $600m target. This was the first close of BEX Fund IV, with...
by Sebastian | Mar 17, 2022 | News
2021 was a record-breaking year for healthcare investors, bouncing back from the pandemic-induced lull of 2020. Despite the ongoing impacts of Covid-19, however, healthcare private equity saw record-levels of deal volume and disclosed value, with $151bn in capital...
by Sebastian | Mar 17, 2022 | News
EQT, the $80.1bn Stockholm-based private markets investment firm, will acquire Baring Private Equity Asia for €6.8bn. The addition of BPEA’s eight Asia-Pacific offices and €17.7bn in assets under management will go a long way toward achieving EQT’s strategic objective...
